Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB06273_nanopub.RAvwMnZlzru0i3XtNDRJmFX6NEAvkVg2EYA7rNKEY3UtQ#assertion>. }
Showing items 1 to 20 of
20
with 100 items per page.
- drugbank:DB06273 type drugbank_vocabulary:Drug assertion.
- drugbank:DB06273 label "Tocilizumab [drugbank:DB06273]" assertion.
- drugbank:DB06273 seeAlso DB06273 assertion.
- drugbank:DB06273 seeAlso tocilizumab.html assertion.
- drugbank:DB06273 seeAlso actemra-drug.htm assertion.
- drugbank:DB06273 identifier "drugbank:DB06273" assertion.
- drugbank:DB06273 description "Tocilizumab is a recombinant, humanized, anti-human interleukin 6 (IL-6) receptor monoclonal antibody that achieves a significant therapeutic response rate. The light chain is made up of 214 amino acids. The heavy chain is made up of 448 amino acids. The four polypeptide chains are linked intra- and inter-molecularly by disulfide bonds. FDA approved on January 8, 2010." assertion.
- drugbank:DB06273 title "Tocilizumab" assertion.
- drugbank:DB06273 bio2rdf_vocabulary:identifier "DB06273" assertion.
- drugbank:DB06273 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB06273 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB06273" assertion.
- drugbank:DB06273 bio2rdf_vocabulary:x-identifiers.org DB06273 assertion.
- drugbank:DB06273 drugbank_vocabulary:drugbank-id "DB06273" assertion.
- drugbank:DB06273 drugbank_vocabulary:x-cas cas:375823-41-9 assertion.
- drugbank:DB06273 drugbank_vocabulary:x-ahfs ahfs:92:36 assertion.
- drugbank:DB06273 drugbank_vocabulary:x-atc atc:L04AC07 assertion.
- drugbank:DB06273 drugbank_vocabulary:x-kegg kegg:D02596 assertion.
- drugbank:DB06273 drugbank_vocabulary:x-pharmgkb pharmgkb:PA165292659 assertion.
- drugbank:DB06273 drugbank_vocabulary:x-wikipedia wikipedia:Tocilizumab assertion.
- drugbank:DB06273 drugbank_vocabulary:x-ndc ndc:50242-137-01 assertion.